Follow The Filings

MDLN Medline Inc.

Health Care, filed as MEDLINE INC (COM CL A), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 6 managers in 2026 Q2, sold by 4

  • 1 Owner
  • #151
  • Max 4.7%
  • Master 0.12%
  • $461M
  • 1 reduce

In 2026 Q3 John Armitage trimmed Medline.

Who owns this now

Largest portfolio weights among holders, up to 4.7% (John Armitage, Egerton Capital (UK)). Not free-float ownership.

  1. John Armitage Reduce 4.7%

Who owns MDLN

Sorted by value, long equity only, as of 2026 Q3.

History
John Armitage, Egerton Capital (UK) 4.7%, was 6.3% Reduce −19.4% 13,283,017 $461M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by MDLN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MDLN insider trades
  • $515M bought by 4 insiders
  • $14.9B sold by 10 insiders outside a trading plan
  • $3.7M sold by 1 insider under 10b5-1 plans
  1. GIC Private Ltd 10% owner, +2 joint filers
    Sale
    $275M 7,816,987 shares at $35.15 10% of stake
    Traded Oct 8 Filed Oct 13
  2. GIC Private Ltd 10% owner, +2 joint filers
    Sale
    $722M 20.7M shares at $34.90
    Traded Oct 2–6 Filed Oct 6
  3. GIC Private Ltd 10% owner, +2 joint filers
    Sale
    $57.3M 1,600,000 shares at $35.80 6.6% of stake
    Traded Aug 13–14 Filed Aug 17
  4. GIC Private Ltd 10% owner, +2 joint filers
    Sale
    $21M 590,284 shares at $35.58 2.4% of stake
    Traded Aug 7 Filed Aug 11
  5. GIC Private Ltd 10% owner, +2 joint filers
    Sale
    $80M 2,248,612 shares at $35.56 8.3% of stake
    Traded Aug 5–6 Filed Aug 7
  6. Douglas P Golwas Chief Commercial Officer
    Planned sale
    $3.7M 100,000 shares at $36.77 81% of stake
    Traded Jun 16 Filed Jun 17
  7. Jessi L Corcoran Principal Accounting Officer
    Buy
    $171K 5,000 shares at $34.15 New stake
    Traded Jun 5 Filed Jun 9
  8. Hellman & Friedman Capital Partners X (Parallel), L.P. 10% owner, +8 joint filers
    Sale
    $1.2B 31.9M shares at $36.54 83% of stake
    Traded May 28 Filed Jun 1
  9. BCP 8 Holdings Mozart Manager L.L.C. 10% owner, +6 joint filers
    Sale
    $1.2B 33.3M shares at $36.54 100% of stake
    Traded May 28 Filed Jun 1
  10. Carlyle Group Inc. 10% owner, +8 joint filers
    Sale
    $1.1B 26.1M shares at $41.00 17% of stake
    Traded Mar 10 Filed Mar 12
  11. Hellman & Friedman Capital Partners X (Parallel), L.P. 10% owner, +8 joint filers
    Sale
    $1.1B 26.1M shares at $40.51 77% of stake
    Traded Mar 10 Filed Mar 12

Also filed in the last 12 months, not counted as buying or selling: 68 other transactions, 29 conversions, 25 stock grants, 8 share withholdings for taxes, 1 sale back to the company, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
8-K 7.01
8-K 5.02
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
8-K 5.02
8-K 5.07
8-K 1.01,2.03,8.01,9.01
424B4
S-1
SCHEDULE 13G/A —

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2025
Revenue $28.43B
Gross profit $7.52B
Gross margin * 26.4%
Net income $1.16B
Net margin * 4.1%

Balance sheet

Metric FY2025
Total current assets $10.68B
Total non-current assets * $27.8B
Total assets $38.48B
Total current liabilities $2.49B
Total non-current liabilities $16.71B
Total equity $10.74B

Cash flow

Metric FY2025
Cash from operations $1.74B
Cash from investing -$474M
Cash from financing $399M
Net change in cash $1.69B

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.